NCT02681796

Epidural Analgesia Use in Pancreatic Resections

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.

Conditions

• Cancer of Pancreas
• Cancer of the Pancreas
• Pancreas Cancer
• Pancreas Neoplasms
• Pancreatic Cancer

Interventions

Type	Name	Description
DRUG	Bupivacaine

Timeline

• Start date: 2016-06-07
• Primary completion: 2020-02-07
• Completion: 2020-02-07
• First posted: 2016-02-12
• Last updated: 2020-03-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study